Funded Projects › HORIZON
LEOPARD · Liver Electronic Offering Platform with Artificial intelligence-based Devices
Liver transplantation (LT) is a life-saving procedure for decompensated cirrhosis (DC) and hepato-cellular carcinoma (HCC). Its efficacy is hampered by the risk of death/drop-out on the Wait List (WL). This risk is driven by organ shortage and is mitigated by organ offering schemes. According to a sickest first policy, offering schemes prioritize LT candidates with the highest risk of dying, as assessed by predictive models. To drive allocation, Organ Sharing Organizations (OSOs) use a 20-year-old model, the MELD, predicting mortality in DC but not in HCC. Because of a dramatic increase in % of HCC candidates (40% against 10% in early 20ties), MELD schemes are increasingly inaccurate, with persisting 15 to 30% mortality in countries with low/medium donation rate. This scenario, together with advances in prognosis in DC and HCC candidates and statistics, prompts LT community to look for up-dated algorithms to refine offering schemes. To address this issue, key European LT stakeholders including OSOs, experts in LT, Statisticians, Research Labs and SME joined LEOPARD. Building on an innovative, harmonized OSOs pre-LT dataset and advances in modeling, LEOPARD propose to design and validate 1) an AI-based LEOPARD predictive algorithm outperforming current allocation models by better stratifying patients on the risk of mortality, to be proposed OSOs to drive allocation; 2) DC & HCC LEOPARD calculators available for professional for assistance in complex decision-making processes; 3) OMICs/radiomics predictive signatures integrated in a prototype 3rd-generation exploratory model. We expect to generate computational tools improving candidates’ outcomes, with more patients transplanted on time. Adoption of these tools should result in harmonization of European heterogeneous prioritization schemes, and in a signification reduction in disparities of access to LT, a major objective pointed out by EC. LEOPARD should place Europe in leading position for organ offering schemes.
Consortium · 18 organisations
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
FR · €2,491,841
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK
FR · €876,799
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
FR · €228,575
ISTITUTO SUPERIORE DI SANITA
IT · €389,388
AGENCE DE LA BIOMEDECINE
FR · €147,589
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA
ES · €273,025
STICHTING EUROTRANSPLANT INTERNATIONAL FOUNDATION
NL · €41,250
UNIVERSITE DU LUXEMBOURG
LU · €656,128
UNIVERSITATSKLINIKUM HEIDELBERG
DE
UNIVERSITE PARIS CITE
FR
EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER
CH
OPHIOMICS - INVESTIGACAO E DESENVOLVIMENTO EM BIOTECNOLOGIA SA
PT · €358,558
EUROPEAN SOCIETY FOR ORGAN TRANSPLANTATION
NL · €214,831
EUROPEAN LIVER PATIENTS ASSOCIATION
BE · €83,125
EPSA INNOVATION FRANCE
FR · €299,375
ORGANIZACION NACIONAL DE TRASPLANTES
ES
EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF)
ES · €260,375
Fédération Nationale des Malades et Transplantés Hépatiques
FR
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.